Porphyria

N Engl J Med. 2017 Aug 31;377(9):862-872. doi: 10.1056/NEJMra1608634.

Authors

D Montgomery Bissell¹, Karl E Anderson¹, Herbert L Bonkovsky¹

Affiliation

¹ From the Department of Medicine, Division of Gastroenterology and Porphyria Center, University of California, San Francisco, San Francisco (D.M.B.); the Departments of Preventive Medicine and Community Health and Internal Medicine, Division of Gastroenterology and Hepatology, University of Texas Medical Branch, Galveston (K.E.A.); and the Department of Gastroenterology, Wake Forest School of Medicine, Winston-Salem, NC (H.L.B.).

PMID: 28854095
DOI: 10.1056/NEJMra1608634

No abstract available

Publication types

Review

MeSH terms

Female
Heme / biosynthesis
Hemin / therapeutic use
Humans
Male
Phlebotomy
Porphobilinogen / blood
Porphyria Cutanea Tarda* / complications
Porphyria Cutanea Tarda* / diagnosis
Porphyria Cutanea Tarda* / therapy
Porphyria, Acute Intermittent* / complications
Porphyria, Acute Intermittent* / diagnosis
Porphyria, Acute Intermittent* / therapy
Porphyrins / analysis
Prognosis
Protoporphyria, Erythropoietic* / complications
Protoporphyria, Erythropoietic* / diagnosis
Protoporphyria, Erythropoietic* / therapy
RNA, Small Interfering / therapeutic use
Sunlight / adverse effects
Symptom Assessment

Substances

Porphyrins
RNA, Small Interfering
Heme
Hemin
Porphobilinogen